FDA Investigator: Lewis K. Antwi

- Lewis K. Antwi first started conducting FDA inspections in 2015, with the last inspection in 2024. Over that time, Lewis K. Antwi has conducted 129 inspections at 90 companies across 111 sites.

Get Lewis Antwi's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 FinVector Oy, Kuopio | 2024

Out-of-stock
Lewis K. Antwi
Biologics Form 483

FDA 483 Lonza Biologics, Inc., Portsmouth | 2024

Out-of-stock
Lewis K. Antwi
Biologics Form 483

FDA 483 Sanofi Winthrop Industrie, Lyon | 2023

Out-of-stock
Lewis K. Antwi
Biologics Form 483

FDA 483 Bavarian Nordic A/S, Kvistgard | 2023

Out-of-stock
Lewis K. Antwi
Biologics Form 483

FDA 483 Seqirus Vaccines Limited, Liverpool | 2023

Out-of-stock
Lewis K. Antwi
Biologics Form 483

FDA 483 LFB Biomanufacturing S.A.S.U, Ales | 2022

Out-of-stock
Lewis K. Antwi
Biologic Form 483

FDA 483 GlaxoSmithKline Biologicals, Saint-Amand-Les-Eaux | 2022

Out-of-stock
Lewis K. Antwi
Biologics Form 483

FDA 483 Kedrion S.p.A., Gallicano | 2022

Out-of-stock
Lewis K. Antwi
Biologic Form 483

FDA 483 National Genetics Institute, Los Angeles | 2022

Out-of-stock
Lewis K. Antwi
Biologic Form 483